Route of administration other than oral for concomitant me­di­cation [Bioanalytics]

posted by jag009  – NJ, 2020-02-04 20:43 (1566 d 13:24 ago) – Posting: # 21145
Views: 2,391

❝ We have given concomitant medication to subjects during clinical phase and the route of administration was topical, local (eye drops), IV, IM.


❝ Can anyone suggest me :confused::confused: if it is required to include these medications in concomitant medication experiment if the route of administration is other than oral (e.g. IV, topical, eye drops) during clinical phase?


Not sure if this answers your question(I think so but..):
Why not? For both safety and bioanalytical reasons.

J

Complete thread:

UA Flag
Activity
 Admin contact
23,033 posts in 4,835 threads, 1,643 registered users;
42 visitors (0 registered, 42 guests [including 13 identified bots]).
Forum time: 11:07 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5